Key Facts

  • Company: UC San Diego Health
  • Company Size: 30,000+ employees, 1M+ annual patient visits
  • Location: San Diego, California
  • AI Tool Used: COMPOSER deep learning model, Mission Control ops center, Epic GPT-4
  • Outcome Achieved: 17% sepsis mortality reduction, 50 lives saved/year, enhanced patient throughput

Want to achieve similar results with AI?

Let us help you identify and implement the right AI solutions for your business.

The Challenge

Sepsis, a life-threatening condition, poses a major threat in emergency departments, with delayed detection contributing to high mortality rates—up to 20-30% in severe cases. At UC San Diego Health, an academic medical center handling over 1 million patient visits annually, nonspecific early symptoms made timely intervention challenging, exacerbating outcomes in busy ERs [1][2]. A randomized study highlighted the need for proactive tools beyond traditional scoring systems like qSOFA.

Hospital capacity management and patient flow were further strained post-COVID, with bed shortages leading to prolonged admission wait times and transfer delays. Balancing elective surgeries, emergencies, and discharges required real-time visibility [3][4]. Safely integrating generative AI, such as GPT-4 in Epic, risked data privacy breaches and inaccurate clinical advice [4].

These issues demanded scalable AI solutions to predict risks, streamline operations, and responsibly adopt emerging tech without compromising care quality.

The Solution

UC San Diego Health implemented COMPOSER, a deep learning model trained on electronic health records to predict sepsis risk up to 6-12 hours early, triggering Epic Best Practice Advisory (BPA) alerts for nurses [2][5]. This quasi-experimental approach across two ERs integrated seamlessly with workflows [5].

Mission Control, an AI-powered operations command center funded by $22M, uses predictive analytics for real-time bed assignments, patient transfers, and capacity forecasting, reducing bottlenecks [3][4]. Led by Chief Health AI Officer Karandeep Singh, it leverages data from Epic for holistic visibility.

For generative AI, pilots with Epic's GPT-4 enable NLP queries and automated patient replies, governed by strict safety protocols to mitigate hallucinations and ensure HIPAA compliance [4]. This multi-faceted strategy addressed detection, flow, and innovation challenges.

Quantitative Results

  • Sepsis in-hospital mortality: 17% reduction
  • Lives saved annually: 50 across two ERs
  • Sepsis bundle compliance: Significant improvement
  • 72-hour SOFA score change: Reduced deterioration
  • ICU encounters: Decreased post-implementation
  • Patient throughput: Improved via Mission Control

Ready to transform your business with AI?

Book a free consultation to explore how AI can solve your specific challenges.

Implementation Details

Overview of AI Ecosystem

UC San Diego Health, under Chief Health AI Officer Karandeep Singh, built a comprehensive AI framework integrating predictive and generative technologies. Launched in phases from 2021-2024, it started with sepsis prediction and expanded to operations via Mission Control and gen AI pilots, all anchored in Epic EHR[4].

Sepsis Prediction: COMPOSER Model

The cornerstone is COMPOSER, a deep learning algorithm analyzing 50+ variables like vitals and labs. Implemented January 2021-April 2023 in two EDs, it triggers nurse-facing BPAs ~6 hours pre-sepsis, outperforming baselines. A before-after quasi-experimental study on 6,217 patients validated impact via propensity matching[2][5]. Training used de-identified data, with ongoing retraining for accuracy.

Mission Control Command Center

Funded by $22M investment, Mission Control—opened in 2023—centralizes AI-driven ops. Dashboards predict bed turnover, discharge readiness, and OR scheduling using predictive analytics. Real-time ML models forecast capacity peaks, automating transfers and reducing admission delays by hours. Integrated with Epic, it supports 1,200+ beds across facilities[3][4].

Generative AI Integration

Piloting Epic GPT-4, UCSD enables ambient documentation, patient summaries, and query responses. Safeguards include human oversight, custom fine-tuning, and audits. Early tests show time savings for clinicians, with expansion planned[4]. Ethical governance via AI council ensures equity and safety.

Timeline and Approach

2021: COMPOSER pilot. 2022: RCT validation. 2023: Mission Control launch, gen AI tests. Iterative via agile sprints, clinician feedback, and partnerships (e.g., Epic). Challenges like data silos overcome by FHIR standards; regulatory hurdles via IRB approvals[1][5]. Scalability now system-wide, with ROI tracking.

Interested in AI for your industry?

Discover how we can help you implement similar solutions.

Results

The deployment yielded transformative outcomes, with COMPOSER reducing sepsis in-hospital mortality by 17% in a rigorous study, directly saving an estimated 50 lives annually across two ERs alone[1][4]. Sepsis bundle compliance surged, minimizing 72-hour Sequential Organ Failure Assessment (SOFA) deteriorations and cutting ICU encounters, boosting ICU-free days[5]. Extrapolated system-wide, impacts amplify amid 1M+ visits. Mission Control revolutionized patient flow, slashing admission wait times and optimizing hospital capacity during surges—key post-COVID. Predictive models enable proactive staffing and transfers, enhancing throughput without added beds[3]. Funded by $22M, ROI emerges via efficiency gains, positioning UCSD as a leader[7]. Generative AI pilots with Epic GPT-4 freed clinician time for care, with safe NLP improving summaries and replies. Ongoing expansions under Singh's vision yield outcomes-based AI, earning accolades as top innovator. Future scales to readmissions, equity analytics[4][6].

Contact Us!

0/10 min.

Contact Directly

Your Contact

Philipp M. W. Hoffmann

Founder & Partner

Address

Reruption GmbH

Falkertstraße 2

70176 Stuttgart

Social Media